TrialBMC cancer2022

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer.

Qin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.